BioCentury
ARTICLE | Clinical News

Anergen preclinical data

November 6, 1995 8:00 AM UTC

ANRG (Redwood City, Calif.) presented data showing protection from IDDM-AnergiX against disease in a mouse model.

The product consists of a soluble form of MHC class II coupled with a glutamic acid decarboxylase peptide, which is suspected to be the antigen epitope of the autoimmune attack that leads to Type I diabetes. ...